Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

25
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
25
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

60
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
60
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

36
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
36
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.4K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.4K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

628
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
628

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evaluation of the impact of a national facilitated antimicrobial stewardship e-learning course on learners' practice in Egypt.

JAC-antimicrobial resistance·2026
Same author

Neuro-Sweet syndrome.

Clinical and experimental dermatology·2024
Same author

REPAIRS Delphi: A UK and Ireland Consensus Statement on the Management of Infected Arterial Pseudoaneurysms Secondary to Groin Injecting Drug Use.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2024
Same author

Changing Incidence and Characteristics of Nontuberculous Mycobacterial Infections in Scotland and Comparison With <i>Mycobacterium tuberculosis</i> Complex Incidence (2011 to 2019).

Open forum infectious diseases·2023
Same author

Introducing the global antimicrobial stewardship partnership hub (GASPH): creating conditions for successful global partnership collaboration.

JAC-antimicrobial resistance·2022
Same author

Acute infections in people who inject drugs.

BMJ (Clinical research ed.)·2022

Related Experiment Video

Updated: Mar 25, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

25.3K

MRSA: treating people with infection.

Nikolas Rae1, Anna Jarchow-MacDonald, Dilip Nathwani

  • 1Ninewells Hospital and Medical School, Dundee, UK.

BMJ Clinical Evidence
|February 17, 2016
PubMed
Summary

This systematic overview evaluated treatments for methicillin-resistant Staphylococcus aureus (MRSA) infections. It categorized the efficacy of five key interventions, providing insights into their effectiveness and safety for treating MRSA.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) confers resistance to beta-lactam antibiotics.
  • MRSA colonization is common, but it can cause severe infections, particularly in vulnerable patient groups.
  • Approximately 8% of Staphylococcus aureus bloodstream infections in England, Wales, and Northern Ireland are MRSA.

Purpose of the Study:

  • To systematically review the clinical effects of selected treatments for MRSA infections across all body sites.
  • To provide an evidence-based overview of MRSA treatment efficacy and safety.

Main Methods:

  • A systematic overview methodology was employed, searching major biomedical databases up to June 2014.
  • Included studies were critically appraised, with 15 systematic reviews and one randomized controlled trial added at this update.

More Related Videos

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.8K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

25.3K
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.8K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K
  • GRADE evaluations were performed for 12 PICO (Population, Intervention, Comparison, Outcome) combinations.

    • Main Results:

    • The search identified 312 studies, with 78 full publications reviewed.
    • Fifteen systematic reviews and one RCT were incorporated, alongside six additional studies.
    • GRADE assessments informed the evaluation of treatment effectiveness and safety.

    Conclusions:

    • The efficacy of five key interventions for MRSA infections was categorized.
    • Evaluated interventions included cephalosporins (ceftobiprole, ceftaroline), daptomycin, linezolid, quinupristin-dalfopristin, and tigecycline.
    • This overview provides a categorized assessment of the effectiveness and safety of these MRSA treatments.